Viemed Healthcare, Inc.
VMD
$8.71
-$0.51-5.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.51% | 23.98% | 14.72% | 16.87% | 19.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.51% | 23.98% | 14.72% | 16.87% | 19.62% |
| Cost of Revenue | 30.63% | 29.35% | 19.26% | 24.33% | 31.83% |
| Gross Profit | 22.04% | 20.29% | 11.67% | 11.67% | 12.54% |
| SG&A Expenses | 15.73% | 17.20% | 11.43% | 17.28% | 17.11% |
| Depreciation & Amortization | 12.83% | 14.08% | -6.37% | -16.14% | -20.97% |
| Other Operating Expenses | 93.83% | 84.06% | 78.64% | -188.46% | -3,900.00% |
| Total Operating Expenses | 23.81% | 22.93% | 15.31% | 19.77% | 20.66% |
| Operating Income | 40.34% | 34.69% | 7.63% | -38.35% | 11.33% |
| Income Before Tax | 26.99% | -6.62% | 121.07% | 72.65% | 24.21% |
| Income Tax Expenses | 16.48% | -3.70% | 123.05% | 83.78% | 17.64% |
| Earnings from Continuing Operations | 31.46% | -7.81% | 120.04% | 69.06% | 27.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -63.89% | -222.22% | -933.33% | -- | -- |
| Net Income | 30.65% | -9.41% | 115.05% | 63.76% | 24.13% |
| EBIT | 40.34% | 34.69% | 7.63% | -38.35% | 11.33% |
| EBITDA | 29.54% | 25.26% | 8.59% | -7.27% | 9.39% |
| EPS Basic | 34.09% | -8.92% | 111.38% | 60.87% | 22.48% |
| Normalized Basic EPS | 40.69% | 27.11% | 48.01% | -50.13% | 8.31% |
| EPS Diluted | 29.77% | -9.82% | 111.38% | 50.00% | 35.79% |
| Normalized Diluted EPS | 41.61% | 27.28% | 48.73% | -50.27% | 6.81% |
| Average Basic Shares Outstanding | -2.59% | -0.60% | 1.78% | 1.83% | 1.39% |
| Average Diluted Shares Outstanding | -3.29% | -0.70% | 1.31% | 2.58% | 2.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |